Literature DB >> 7416954

Efficacy of the gallbladder for drainage in biliary obstruction: a comparison of malignant and benign disease.

M T Dayton, L W Traverso, W P Longmire.   

Abstract

To evaluate the efficacy of the gallbladder as an alternate drainage route in biliary obstruction, we reviewed the charts of 79 patients who underwent 80 cholecystoenterostomy (CCE) procedures at the UCLA Hospital during the period between 1955 and 1978. Among these procedures, 62 (77.5%) were done for malignant obstruction and 18 (22.5%) for benign obstruction; three patients with malignancy and one with benign disease were unavailable for follow-up. The CCE procedure failed in nine patients (11.8), five of 59 cases involving malignancy (8.5%), and four of 17 (23.5%) for benign disease. The 26-month cumulative patency was found to be 78.9% in malignant disease and 68.6% in benign disease. The combined failure rate of cholecystojejunostomy was 8.3%, compared to 30.8% with cholecystoduodenostomy. "Gross inflammation" was the only variable predictive of future CCE failure. The study suggests that CCE should be used primarily in terminal malignancy when a simple, short-term biliary bypass is desired.

Entities:  

Mesh:

Year:  1980        PMID: 7416954     DOI: 10.1001/archsurg.1980.01380090054013

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  3 in total

Review 1.  Obstructive biliary tract disease.

Authors:  T T White
Journal:  West J Med       Date:  1982-06

Review 2.  Cystic duct patency in malignant obstructive jaundice. An ERCP-based study relevant to the role of laparoscopic cholecystojejunostomy.

Authors:  P R Tarnasky; R E England; L M Lail; T N Pappas; P B Cotton
Journal:  Ann Surg       Date:  1995-03       Impact factor: 12.969

3.  Long-term outcome of cholecystoenterostomy as a definitive biliary drainage procedure for benign disease.

Authors:  A J Oishi; M G Sarr; D M Nagorney; M D Traynor; P Mucha
Journal:  World J Surg       Date:  1995 Jul-Aug       Impact factor: 3.352

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.